Samsung in Talks to Buy Alzheimer's Drug Maker for $42 Billion: Report

Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).

from NDTV Gadgets - Latest https://ift.tt/3Jtfszt

Comments

Popular posts from this blog

OnePlus 13T Teased to Launch in Three Colour Options

Iceland lost 750 sq km of glaciers over the last two decades due to global warming

Samsung Galaxy Tab S9 FE+ India Launch Likely Soon as Company Drops New Teaser